Paloma Partners’s bluebird bio BLUE Stock Holding History

Paloma Partners’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-594	Closed	-$415K	–	1673
2020 Q3	$415K	Buy	+594	New	+$463K	0.01%	1286
2019 Q4	–	Sell	-309	Closed	-$369K	–	2156
2019 Q3	$369K	Sell	309 -3,736	-92%	-$5.71M	0.01%	1390
2019 Q2	$6.67M	Buy	4,045 +2,541	+169%	+$4.4M	0.11%	150
2019 Q1	$3.06M	Buy	+1,504	New	+$2.65M	0.07%	311
2018 Q3	–	Sell	-11,034	Closed	-$22.8M	–	1562
2018 Q2	$22.4M	Buy	+11,034	New	+$25.2M	0.41%	24
2018 Q1	–	Sell	-89	Closed	-$205K	–	1949
2017 Q4	$205K	Sell	89 -43	-33%	-$87.3K	﹤0.01%	1727
2017 Q3	$235K	Buy	+132	New	+$184K	﹤0.01%	1911
2016 Q4	–	Sell	-1,409	Closed	-$1.24M	–	1968
2016 Q3	$1.24M	Buy	+1,409	New	+$1.02M	0.02%	854
2015 Q4	–	Sell	-1,019	Closed	-$1.13M	–	1710
2015 Q3	$1.13M	Sell	1,019 -2,467	-71%	-$4.5M	0.03%	582
2015 Q2	$7.6M	Buy	+3,486	New	+$7.1M	0.15%	142

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Paloma Partners's BLUE Position: Q4 2020 in Review

Paloma Partners sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 594 shares — an estimated $415K sold.

Paloma Partners first reported a position in BLUE in Q2 2015 and held it in 10 quarters. The position peaked at $22.4M in Q2 2018. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

Paloma Partners reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 594 bluebird bio shares in Q4 2020, an estimated $415K.
Paloma Partners first reported a position in bluebird bio in Q2 2015 and held it in 10 quarters.
Paloma Partners's bluebird bio position peaked at $22.4M in Q2 2018.
262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.